Global Industrial Co officer Thomas Axmacher filed a Form 144 notice of proposed sale on November 9, 2026, covering 648 shares of common stock acquired through the company's employee stock purchase plan.
United States Antimony Corporation filed a Form 8-K on November 9, 2026, announcing that its Third Quarter 2026 Financial and Operating Results will be released via news release, conference call, and webcast on Thursday, November 12, 2026, at 4:15 p.m. Eastern time.
Vikram Verghese, an officer of Heartflow, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 3,587 shares of Heartflow common stock through Fidelity Brokerage Services LLC on NASDAQ:HTFL.
The Bank of Nova Scotia filed a free writing prospectus on November 9, 2026, disclosing terms for a structured note linked to the Class A common stock of Alphabet Inc., with a stated maturity date of November 15, 2029.
Qatar Investment Authority filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,804,360 shares of common stock in Iambic Therapeutics, Inc., representing 5.8% of the class as of October 15, 2026.
Inflection Point Acquisition Corp. VI filed a Form 425 on November 9, 2026, disclosing a press release issued by Quantum Space, LLC on November 7, 2026, announcing that Quantum Space had been selected as a subcontractor on a $185 million NASA Moon Base Transportation …
CNH Industrial N.V. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting third-quarter net income attributable to the company of $30 million and nine-month net income of $175 million.
IPFX PubCo, Inc. filed a Form 425 on November 9, 2026, disclosing two press releases issued by Quantum Space, LLC, covering a $185 million NASA Moon Base Transportation contract award and an upcoming Virtual Analyst Day tied to Quantum Space's planned public listing via …
Director Frank G. Pellegrino of Citizens & Northern Corp filed a Form 4 on November 9, 2026, disclosing a purchase of 254 shares of common stock on November 6, 2026, made under a Rule 10b5-1 written plan.
Quest Diagnostics officer Patrick Plewman filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 11,717 shares of Quest Diagnostics Inc. common stock on the New York Stock Exchange.